DiaMedica Therapeutics Inc. appointed Tanya N. Lewis to the Board, effective March 1, 2023. On and effective March 9, 2023, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, the Board appointed Ms. Lewis as a member of the Compensation Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.85 USD | -1.04% | -6.25% | +0.35% |
05-23 | DiaMedica Therapeutics Inc. Elects Rick Pauls as Director | CI |
05-09 | Transcript : DiaMedica Therapeutics Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.35% | 109M | |
+9.83% | 118B | |
+10.80% | 106B | |
-10.84% | 23.4B | |
-1.69% | 22.1B | |
-10.23% | 18.34B | |
-41.92% | 16.59B | |
-15.11% | 15.97B | |
+6.62% | 14.03B | |
+17.53% | 11.67B |
- Stock Market
- Equities
- DMAC Stock
- News DiaMedica Therapeutics Inc.
- DiaMedica Therapeutics Inc. Appoints Lewis as A Member of the Compensation Committee